Abstract
mortality independent of MELD-Xi and Heartmate II (HMRS) risk scores. Discriminatory power of RDW was comparable to MELD-Xi and Heartmate II risk scores (Figure 1B). Conclusion: These findings suggest that RDW, a simple and inexpensive test that is available through routine complete blood count, can be successfully utilized for mortality risk assessment in CF-LVAD candidates. RDW should be incorporated into future CF-LVAD risk models.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
